News
In a pivotal randomised controlled trial, the BNT162b2 mRNA vaccine (tozinameran, Pfizer–BioNTech) showed 95% or greater efficacy against symptomatic and severe COVID-19 disease due to SARS-CoV-2. 1 ...
21h
AZoLifeSciences on MSNVIRMA Protein Identified as Key Regulator of Ribosome Biogenesis in Brain DevelopmentRibosomes are tiny molecular machines inside all living cells that build proteins, and ribosome biogenesis is the complex, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results